Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Clinical Trial of GD-11 for Injection in the Treatment of Acute Ischemic Stroke

NCT06299579 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT06299579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06299579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Clinical Trial of GD-11 for Injection in the Treatment of Acute Ischemic Stroke
Lead sponsor
Beijing Tiantan Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
February 29, 2024
Completion date
December 31, 2025
Enrollment
980 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke